Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Clovis Oncology Stock Forecast NASDAQ:CLVS
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-06 | - | HC Wainwright & Co. | - | Downgrades | Buy Neutral |
| 2022-05-05 | 381.93% | HC Wainwright & Co. | $5.00 $4.00 | Maintains | Buy |
| 2021-09-21 | 984.34% | HC Wainwright & Co. | $10.00 $9.00 | Maintains | Buy |
| 2021-08-05 | 1104.82% | HC Wainwright & Co. | $12.00 $10.00 | Maintains | Buy |
| 2021-05-05 | 1345.78% | HC Wainwright & Co. | $13.00 $12.00 | Maintains | Buy |
| 2020-11-06 | 1707.23% | HC Wainwright & Co. | $23.00 $15.00 | Maintains | Buy |
| 2020-11-06 | 261.45% | SVB Leerink | $4.00 $3.00 | Maintains | Underperform |
| 2020-05-22 | 3393.98% | HC Wainwright & Co. | $33.00 $29.00 | Reiterates | Buy |
| 2020-05-20 | 381.93% | SVB Leerink | $5.00 $4.00 | Maintains | Underperform |
| 2020-05-18 | 3875.9% | HC Wainwright & Co. | $29.00 $33.00 | Maintains | Buy |
| 2020-05-06 | 3393.98% | HC Wainwright & Co. | $27.00 $29.00 | Reiterates | Buy |
| 2020-04-27 | 502.41% | SVB Leerink | $5.00 | Downgrades | Market Perform Underperform |
| 2020-04-09 | 622.89% | B of A Securities | $6.00 | Downgrades | Neutral Underperform |
| 2020-01-23 | 1104.82% | B of A Securities | $7.00 $10.00 | Maintains | Neutral |
| 2019-11-19 | 863.86% | Evercore ISI Group | $8.00 | Downgrades | Outperform In-Line |
| 2019-10-08 | 261.45% | Goldman Sachs | $13.00 $3.00 | Maintains | Sell |
| 2019-09-24 | - | SVB Leerink | - | Downgrades | Outperform Market Perform |
| 2019-08-13 | 743.37% | B of A Securities | $13.00 $7.00 | Downgrades | Buy Neutral |
| 2019-08-02 | - | Guggenheim | - | Downgrades | Buy Neutral |
| 2019-05-29 | 1707.23% | Goldman Sachs | $17.00 $15.00 | Downgrades | Neutral Sell |
CLVS Stock Trend
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.74 is broken, it will firstly indicate a stronger fall rate.
Given the current short-term trend, the stock is expected to fall -5.53% during the next 3 months and, with a 90% probability hold a price between $0.70 and $2.72 at the end of this 3-month period.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-18 | $0.74 | $1.81 | $2.88 |
| 2022-05-19 | $0.73 | $1.81 | $2.88 |
| 2022-05-20 | $0.73 | $1.80 | $2.87 |
| 2022-05-23 | $0.73 | $1.80 | $2.87 |
| 2022-05-24 | $0.73 | $1.80 | $2.87 |
| 2022-05-25 | $0.72 | $1.79 | $2.86 |
| 2022-05-26 | $0.72 | $1.79 | $2.86 |
| 2022-05-27 | $0.72 | $1.79 | $2.86 |
| 2022-05-31 | $0.71 | $1.79 | $2.86 |
| 2022-06-01 | $0.71 | $1.78 | $2.85 |
| 2022-06-02 | $0.71 | $1.78 | $2.85 |
| 2022-06-03 | $0.71 | $1.78 | $2.85 |
| 2022-06-06 | $0.70 | $1.77 | $2.84 |
| 2022-06-07 | $0.70 | $1.77 | $2.84 |
| 2022-06-08 | $0.70 | $1.77 | $2.84 |
| 2022-06-09 | $0.70 | $1.77 | $2.84 |
| 2022-06-10 | $0.69 | $1.76 | $2.83 |
| 2022-06-13 | $0.69 | $1.76 | $2.83 |
| 2022-06-14 | $0.69 | $1.76 | $2.83 |
| 2022-06-15 | $0.68 | $1.75 | $2.83 |
| 2022-06-16 | $0.68 | $1.75 | $2.82 |
| 2022-06-17 | $0.68 | $1.75 | $2.82 |
| 2022-06-21 | $0.68 | $1.75 | $2.82 |
| 2022-06-22 | $0.67 | $1.74 | $2.81 |
| 2022-06-23 | $0.67 | $1.74 | $2.81 |
| 2022-06-24 | $0.67 | $1.74 | $2.81 |
| 2022-06-27 | $0.66 | $1.73 | $2.81 |
| 2022-06-28 | $0.66 | $1.73 | $2.80 |
| 2022-06-29 | $0.66 | $1.73 | $2.80 |
| 2022-06-30 | $0.66 | $1.73 | $2.80 |
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates, which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is under review with the U.S. and E.U. regulatory authorities for the treatment of non-small cell lung cancer; Rucapar... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 108 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
